Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital

Revista Iberoamericana de Micologia

Volumn 25, Issue 4, 2008, Pages 221-225

  Ribeiro, Mariceli Araujo ^a   Alastruey Izquierdo, Ana ^b   Gomez Lopez, Alicia ^b   Rodriguez Tudela, Juan Luis ^b   Cuenca Estrella, Manuel ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antifungal susceptibility; Molecular identification; Trichosporon asahii; Trichosporon inkin

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT; ECHINOCANDIN; TRIAZOLE DERIVATIVE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BASIDIOMYCETES; BRAZIL; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN IDENTIFICATION; TRICHOSPORON; TRICHOSPORON ASAHII; TRICHOSPORON FAECALE; TRICHOSPORON INKIN; ANTIBODY SPECIFICITY; ANTIFUNGAL RESISTANCE; CLASSIFICATION; COMPARATIVE STUDY; CROSS INFECTION; DERMATOMYCOSIS; DRUG EFFECT; FEMALE; FUNGEMIA; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOSIS; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTION; STATISTICS; UNIVERSITY HOSPITAL; URINE; VAGINITIS;

TRICHOSPORON ASAHII; TRICHOSPORON FAECALE; TRICHOSPORON INKIN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAZIL; CROSS INFECTION; DERMATOMYCOSES; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FLUCYTOSINE; FUNGEMIA; HOSPITALS, UNIVERSITY; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; MYCOSES; ONYCHOMYCOSIS; OPPORTUNISTIC INFECTIONS; ORGAN SPECIFICITY; TRIAZOLES; TRICHOSPORON; URINE; VAGINITIS;

EID: 61449322628     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(08)70053-6     Document Type: Article

References (42)

1. Abliz P, Fukushima K, Takizawa K, Yang R, Li R, Nishimura K. Identification of the first isolates of Trichosporon asahii var asahii from disseminated trichosporonosis in China. Diagn Microbiol Infect Dis 2002; 44: 17-22.
2. Arikan S, Hascelik G. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates. Diagn Microbiol Infect Dis 2002; 43: 107-111.
3. Bassetti M, Bisio F, Di Biagio A, Pierri I, Balocco M, Soro O, Cruciani M, Bassetti D. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. J Antimicrob Chemother 2004; 54: 575-577.
4. Chagas-Neto TC, Chaves GM, Colombo AL. Update on the genus Trichosporon. Mycopathologia 2008; 166: 121-132.
5. Chowdhary A, Ahmad S, Khan ZU, Doval DC, Randhawa HS. Trichosporon asahii as an emerging etiologic agent of disseminated trichosporonosis: A case report and an update. Indian J Med Microbiol 2004; 22: 16-22.
6. Crowther KS, Webb AT, McWhinney PH. Trichosporon inkin peritonitis in a patient on continuous ambulatory peritoneal dialysis returning from the Caribbean. Clin Nephrol 2003; 59: 69-70.
7. Cuenca-Estrella M, Moore CB, Barchiesi F, Bille J, Chryssanthou E, Denning DW, Donnelly JP, Dromer F, Dupont B, Rex JH, Richardson MD, Sancak B, Verweij PE, Rodríguez-Tudela JL. AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 2003; 9: 467-474.
8. Ebright JR, Fairfax MR, Vazquez JA. Trichosporon asahii, a non- Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin Infect Dis 2001; 33: E28-E30.
9. Ghiasian SA, Maghsood AH, Mirhendi SH. Disseminated, fatal Trichosporon asahii infection in a bone marrow transplant recipient. J Microbiol Immunol Infect 2006; 39: 426-429.
10. Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, Martino P; GIMEMA Infection Program. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005; 43: 1818-1828
11. Goodman D, Pamer E, Jakubowski A, Morris C, Sepkowitz K. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis 2002; 35: 35-36.
12. Guého E, Smith MT, de Hoog GS, Billon-Grand G, Christen R, Batenburg-van der Vegte WH. Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek 1992; 61: 289-316.
13. Guého E, Smith MT, Hoog GS. Trichosporon Behrend. In: Kurtzman CP, Fell JW. The yeasts, a taxonomic study. Amsterdam, Elsevier Science, 1998: 854-872.
14. Gross JW, Kan VL. Trichosporon asahii infection in an advanced AIDS patient and literature review. AIDS 2008; 22: 793-795.
15. Hung CC, Chang SC, Chen YC, Tien HF, Hsieh WC. Trichosporon beigelii fungemia in patients with acute leukemia: report of three cases. J Formos Med Assoc 1995; 94:127-131.
16. Koyanagi T, Nishida N, Osabe S, Imamura Y, Yamamoto S, Shichiji A, Nakamura Y. Autopsy case of disseminated Trichosporon inkin infection identified with molecular biological and biochemical methods. Pathol Int 2006; 56: 738-743.
17. Li HM, Du HT, Liu W, Wan Z, Li RY. Microbiological characteristics of medically important Trichosporon species. Mycopathologia 2005; 160: 217-225.
18. Lopes JO, Alves SH, Klock C, Oliveira LT, Dal Forno NR. Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review. Mycopathologia 1997; 139: 15-18.
19. Marty FM, Barouch DH, Coakley EP, Baden LR. Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol 2003; 41: 5317-5320.
20. Meyer MH, Letscher-Bru V, Waller J, Lutz P, Marcellin L, Herbrecht R. Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin Infect Dis 2002; 35: 22-25.
21. Moretti-Branchini ML, Fukushima K, Schreiber AZ, Nishimura K, Papaiordanou PM, Trabasso P, Tanaka R, Miyaji M. Trichosporon species infection in bone marrow transplanted patients. Diagn Microbiol Infect Dis 2001; 39: 161-164.
22. Nakagawa T, Nakashima K, Takaiwa T, Negayama K. Trichosporon cutaneum (Trichosporon asahii) infection mimicking hand eczema in a patient with leukemia. J Am Acad Dermatol 2000; 42: 929-931.
23. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts National Committee for Clinical Laboratory Standards, Wayne, Pa., 2002.
24. Nishiura Y, Nakagawa-Yoshida K., Suga M., Shinoda T., Guého E, Ando M. Assignment and serotyping of Trichosporon species: the causative agents of summer-type hypersensitivity pneumonitis. J Med Vet Mycol 1997; 35: 45-52.
25. Padhye AA, Verghese S, Ravichandran P, Balamurugan G, Hall L, Padmaja P, Fernandez MC. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J Clin Microbiol 2003; 41: 479-482.
26. Panagopoulou P, Evdoridou J, Bibashi E, Filioti J, Sofianou D, Kremenopoulos G, Roilides E. Trichosporon asahii: an unusual cause of invasive infection in neonates. Pediatr Infect Dis J 2002; 21: 169-170.
27. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144-1146.
28. Perparim K, Nagai H, Hashimoto A, Goto Y, Tashiro T, Nasu M. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J Chemother 1996; 8: 445-448.
29. Piwoz JA, Stadtmauer GJ, Bottone EJ, Weitzman I, Shlasko E, Cummingham-Rundles C. Trichosporon inkin lung abscesses presenting as a penetrating chest wall mass. Pediatr Infect Dis J 2000; 19: 1025-1027.
30. Ramos JM, Cuenca-Estrella M, Gutierrez F, Elia M, Rodriguez-Tudela JL. Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism. J Clin Microbiol 2004; 42: 2341-2344.
31. Rastogi VL, Nirwan PS. Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol 2007; 25: 59-61.
32. Rodriguez-Tudela JL, Diaz-Guerra TM, Mellado E, Cano V, Tapia C, Perkins A, Gomez-Lopez A, Rodero L, Cuenca-Estrella M. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob Agents Chemother 2005; 49: 4026-4034.
33. Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, Mellado E, Bernal-Martinez L, Cuenca-Estrella M. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 2007; 58: 435-440.
34. Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M. Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. Antimicrob Agents Chemother 2007; 51: 3599-3604.
35. Sugita T, Nishikawa A, Shinoda T. Identification of Trichosporon asahii by PCR based on sequences of the internal transcribed spacer regions. J Clin Microbiol 1998; 36: 2742-2744
36. Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40: 1826-30
37. Takamura S, Oono T, Kanzaki H, Arata J. Disseminated trichosporonosis with Trichosporon asahii. Eur J Dermatol 1999; 9: 577-579.
38. Tokimatsu I, Kushima H, Hashinaga K, Umeki K, Ohama M, Ishii H, Kishi K, Hiramatsu K, Kadota J. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Int J Antimicrob Agents 2007; 29: 84-88.
39. Uzun O, Arikan S, Kocagoz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn Microbiol Infect Dis 2000; 38: 101-107.
40. Walsh TJ, Newman KR, Moody M, Wharton RC, Wade JC. Trichosporonosis in patients with neoplastic disease. Medicine 1986; 65:268-279.
41. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In Innis MA, Gelfand DH, Sninsky JJ, White TJ. PCR protocols. A Guide to methods and applications. San Diego, Academic Press Inc 1990: 315-324.
42. Yun SJ, Lee JB, Shin MG, Kim SJ, Won YH, Lee SC. Cutaneous abscess by Trichosporon asahii developing on a steroid injection site in a healthy adult. Clin Exp Dermatol 2006; 31: 545-547.